axelar.se
Contattaci
Circa la società
Axelar AB is a Swedish biotechnology company that was founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson and Karolinska Innovations AB/Karolinska Development AB. The company focuses its research and other activities on inhibitors of the insulin-like growth factor-1 (IGF-1) receptor and their applications in important human diseases, especially cancer. Axelar AB is situated in the Karolinska Institutet Science Park, Stockholm, Sweden.
NO
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative